BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 17569133)

  • 1. Pancreatitis after endoscopic retrograde cholangio-pancreatography.
    Abdel Aziz AM; Lehman GA
    World J Gastroenterol; 2007 May; 13(19):2655-68. PubMed ID: 17569133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three-hour post-ERCP amylase level: a useful indicator for early prediction of post-ERCP pancreatitis.
    Lv ZH; Kou DQ; Guo SB
    BMC Gastroenterol; 2020 Apr; 20(1):118. PubMed ID: 32306904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppository naproxen reduces incidence and severity of post-endoscopic retrograde cholangiopancreatography pancreatitis: Randomized controlled trial.
    Mansour-Ghanaei F; Joukar F; Taherzadeh Z; Sokhanvar H; Hasandokht T
    World J Gastroenterol; 2016 Jun; 22(21):5114-21. PubMed ID: 27275104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-endoscopic retrograde cholangio-pancreatography pancreatitis: is time for a new preventive approach?
    Tammaro S; Caruso R; Pallone F; Monteleone G
    World J Gastroenterol; 2012 Sep; 18(34):4635-8. PubMed ID: 23002332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis Using 4-Hour Post-Endoscopic Retrograde Cholangiopancreatography Serum Amylase and Lipase Levels.
    Lee YK; Yang MJ; Kim SS; Noh CK; Cho HJ; Lim SG; Hwang JC; Yoo BM; Kim JH
    J Korean Med Sci; 2017 Nov; 32(11):1814-1819. PubMed ID: 28960034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk Factors for Post-Endoscopic Retrograde Cholangio-Pancreatography Pancreatitis in Children With Chronic Pancreatitis and Its Prediction Using 4-Hour Postprocedure Serum Amylase and Lipase Levels.
    Samanta A; Vadlapudi SS; Srivastava A; Mohindra S; Sen Sarma M; Poddar U; Saraswat VA; Mishra P
    Pancreas; 2024 Mar; 53(3):e247-e253. PubMed ID: 38227737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endoscopic prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis.
    Lee TH; Park DH
    World J Gastroenterol; 2014 Nov; 20(44):16582-95. PubMed ID: 25469026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ERCP-induced and non-ERCP-induced acute pancreatitis: Two distinct clinical entities with different outcomes in mild and severe form?
    Testoni PA; Vailati C; Giussani A; Notaristefano C; Mariani A
    Dig Liver Dis; 2010 Aug; 42(8):567-70. PubMed ID: 20018574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk Factors for Post-Endoscopic Retrograde Pancreatography Pancreatitis: A Retrospective Chart Review in a Regional Hospital in Japan.
    Shimamura T; Miyahara K; Takamori A; Hidaka H; Ito Y; Fujimoto S; Takedomi H; Tsuruoka N; Sakata Y; Eguchi Y; Node K; Noda T; Fujimoto K
    Digestion; 2020; 101(5):557-562. PubMed ID: 31487723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preventing post-endoscopic retrograde cholangiopancreatography pancreatitis: what can be done?
    Hauser G; Milosevic M; Stimac D; Zerem E; Jovanović P; Blazevic I
    World J Gastroenterol; 2015 Jan; 21(4):1069-80. PubMed ID: 25632179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endoscopic retrograde cholangiopancreatography (ERCP)-related adverse events: post-ERCP pancreatitis.
    Rustagi T; Jamidar PA
    Gastrointest Endosc Clin N Am; 2015 Jan; 25(1):107-21. PubMed ID: 25442962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical study on the prevention of post-ERCP pancreatitis by pancreatic duct stenting.
    Pan XP; Dang T; Meng XM; Xue KC; Chang ZH; Zhang YP
    Cell Biochem Biophys; 2011 Dec; 61(3):473-9. PubMed ID: 21739262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors associated with post-ERCP pancreatitis and the effect of pancreatic duct stenting in a pediatric population.
    Troendle DM; Abraham O; Huang R; Barth BA
    Gastrointest Endosc; 2015; 81(6):1408-16. PubMed ID: 25686874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preventing post-ERCP pancreatitis: where are we?
    Testoni PA
    JOP; 2003 Jan; 4(1):22-32. PubMed ID: 12555013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-ERCP pancreatitis and its prevention.
    Frank CD; Adler DG
    Nat Clin Pract Gastroenterol Hepatol; 2006 Dec; 3(12):680-8. PubMed ID: 17130878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reducing the risk of post-endoscopic retrograde cholangiopancreatography pancreatitis.
    Elmunzer BJ
    Dig Endosc; 2017 Nov; 29(7):749-757. PubMed ID: 28636774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of serum amylase and lipase as predictors of the severity of post-endoscopic retrograde cholangiopancreatography pancreatitis.
    Martínez-Segundo U; Pinto-Angulo VM; García-Álvarez J; Cruz-Reyes JM; Briceño-Sáenz G
    Cir Cir; 2020; 88(4):428-434. PubMed ID: 32567590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Etanercept, a TNF-alpha binding agent, is ineffective in the prevention of post-ERCP pancreatitis in canines.
    Buscaglia JM; Simons BW; Prosser BJ; Ruben DS; Giday SA; Magno P; Clarke JO; Shin EJ; Kalloo AN; Kantsevoy SV; Gabrielson KL; Jagannath SB
    JOP; 2008 Jul; 9(4):456-67. PubMed ID: 18648137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for post-ERCP pancreatitis and hyperamylasemia: A retrospective single-center study.
    He QB; Xu T; Wang J; Li YH; Wang L; Zou XP
    J Dig Dis; 2015 Aug; 16(8):471-8. PubMed ID: 25955444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endoscopic pancreatic duct stents reduce the incidence of post-endoscopic retrograde cholangiopancreatography pancreatitis in high-risk patients.
    Sofuni A; Maguchi H; Mukai T; Kawakami H; Irisawa A; Kubota K; Okaniwa S; Kikuyama M; Kutsumi H; Hanada K; Ueki T; Itoi T
    Clin Gastroenterol Hepatol; 2011 Oct; 9(10):851-8; quiz e110. PubMed ID: 21749851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.